{"title":"Case Series: Natural History and Treatment of Thoracic Aortic Sarcoma.","authors":"Calvin L Chao, Nicola M Habash, Mark K Eskandari","doi":"10.1002/jso.28150","DOIUrl":null,"url":null,"abstract":"<p><p>Aortic sarcoma is a rare and aggressive malignancy with a poor prognosis despite surgical resection and vascular reconstruction. We present a case series of patients with thoracic aortic sarcoma, highlighting three distinct clinical scenarios: primary resection, resection following prior thoracic aortic endograft, and nonoperative management. Our findings underscore key aspects of aortic sarcoma management, including its embolic potential, diagnostic challenges, and surgical considerations, particularly when endograft explant is required. Despite limited survival, we advocate for complete resection and vascular reconstruction with adjunctive chemoradiotherapy when feasible. Multidisciplinary collaboration remains paramount to optimize postoperative outcome in this complex pathology.</p>","PeriodicalId":17111,"journal":{"name":"Journal of Surgical Oncology","volume":" ","pages":""},"PeriodicalIF":2.0000,"publicationDate":"2025-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Surgical Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/jso.28150","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Aortic sarcoma is a rare and aggressive malignancy with a poor prognosis despite surgical resection and vascular reconstruction. We present a case series of patients with thoracic aortic sarcoma, highlighting three distinct clinical scenarios: primary resection, resection following prior thoracic aortic endograft, and nonoperative management. Our findings underscore key aspects of aortic sarcoma management, including its embolic potential, diagnostic challenges, and surgical considerations, particularly when endograft explant is required. Despite limited survival, we advocate for complete resection and vascular reconstruction with adjunctive chemoradiotherapy when feasible. Multidisciplinary collaboration remains paramount to optimize postoperative outcome in this complex pathology.
期刊介绍:
The Journal of Surgical Oncology offers peer-reviewed, original papers in the field of surgical oncology and broadly related surgical sciences, including reports on experimental and laboratory studies. As an international journal, the editors encourage participation from leading surgeons around the world. The JSO is the representative journal for the World Federation of Surgical Oncology Societies. Publishing 16 issues in 2 volumes each year, the journal accepts Research Articles, in-depth Reviews of timely interest, Letters to the Editor, and invited Editorials. Guest Editors from the JSO Editorial Board oversee multiple special Seminars issues each year. These Seminars include multifaceted Reviews on a particular topic or current issue in surgical oncology, which are invited from experts in the field.